Kenneth Carekin Kalunian MD
Rheumatoid Arthritis & Related
Professor, Medicine, UCSD School of Medicine
Join to view full profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Kalunian is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1983 - 1985
Olive View/UCLA Medical CenterResidency, Internal Medicine, 1979 - 1983
Saint Louis University School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1980 - 2028
American Board of Internal Medicine Internal Medicine
National Board of Physicians and Surgeons Internal Medicine- National Board of Physicians and Surgeons Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsLitifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC study.Victoria P Werth, Joseph F Merola, Richard Furie, Kenneth Kalunian, Ronald F van Vollenhoven
Journal of the European Academy of Dermatology and Venereology. 2026-09-01 - A population-scale transcriptional atlas of blood and tissue in lupus nephritis.Nicholas W Sugiarto, Siddarth Gurajala, Michelle Curtis, Thomas M Eisenhaure, Arnon Arazi
Science Translational Medicine. 2026-08-19 - 1 citationsBias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.Rima Kaddoura, Sasha Bernatsky, Marie-Eve Beauchamp, Steve Ferreira Guerra, Celline C Almeida-Brasil
Journal of Clinical Epidemiology. 2026-07-01
Journal Articles
- Psychosis in Systemic Lupus ErythematosusAnca Askanase, Kenneth C Kalunian, M A Dooley, Meggan Mackay, Ellen M Ginzler, Daniel J Wallace, Susan Manzi, Cynthia Aranow, Joan T Merrill, Michelle Petri, Diane L K..., Arthritis & Rheumatology
Other
- Clinical manifestations of osteoarthritisKalunian KC
http://www.uptodate.com/contents/clinical-manifestations-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-12-06 - Diagnosis and classification of osteoarthritisKalunian KC
http://www.uptodate.com/contents/diagnosis-and-classification-of-osteoarthritis
UpToDate, Wolters Kluwer Health - 2012-04-17 - Investigational approaches to the pharmacologic therapy of osteoarthritisKalunian KC
http://www.uptodate.com/contents/investigational-approaches-to-the-pharmacologic-therapy-of-osteoart
UpToDate, Wolters Kluwer Health - 2012-10-12
Authored Content
- Novel Serum and Urinary Biomarkers for Use in Diagnosis and Disease Course Management in Lupus NephritisNovember 2022
Press Mentions
Experts Describe Strides Made in Understudied Lupus ArthritisJanuary 1st, 2025- Two Promising Treatment Options for SLENovember 16th, 2022
Baricitinib Helps Lupus Patients with Arthritis or Rash – Phase 2 StudyJuly 24th, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: